Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer

Canan G Nebigil; Michael W Y Chan

doi:10.3389/fcvm.2023.1145780

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer

Front Cardiovasc Med. 2023 Feb 1:10:1145780. doi: 10.3389/fcvm.2023.1145780. eCollection 2023.

Authors

Canan G Nebigil¹, Michael W Y Chan²

Affiliations

¹ Regenerative Nanomedicine, UMR 1260, INSERM, University of Strasbourg, Strasbourg, France.
² Department of Biomedical Sciences, National Chung Cheng University, Chiayi City, Taiwan.

No abstract available

Keywords: anti-cancer drugs; biomarkers; cancer; genetic variance; heart failure; population studies; risk factors.

Publication types

Editorial

Grants and funding

This study was supported by grants Fondation de France (R20085MM), and French government managed by Agence Nationale de la Recherche (ANR-16-ECVD-0005-01) (CN).